Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
暂无分享,去创建一个
[1] H. Bazett,et al. AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS. , 1997 .
[2] A. Moss,et al. ISHNE Guidelines for Electrocardiographic Evaluation of Drug‐related QT Prolongation and Other Alterations in Ventricular Repolarization: Task Force Summary , 2001, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[3] R. Califf,et al. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management. , 2002, American heart journal.
[4] A J Camm,et al. Evaluation of Drug-Induced QT Interval Prolongation , 2001, Drug safety.
[5] R. Califf,et al. Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young , 2004, Circulation.
[6] D. Roden. Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.
[7] M. Crouch,et al. Clinical Relevance and Management of Drug‐Related QT Interval Prolongation , 2003, Pharmacotherapy.